Literature DB >> 29671654

Is personalized medicine a realistic goal in idiopathic pulmonary fibrosis?

Victor J Thannickal1, Veena B Antony1.   

Abstract

Entities:  

Keywords:  3D spheroids; Idiopathic pulmonary fibrosis; T-cells; autoimmunity; biomarkers; cellular invasion; personalized medicine; pulmospheres

Year:  2018        PMID： 29671654      PMCID： PMC6157605          DOI： 10.1080/17476348.2018.1464913

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN： 1747-6348            Impact factor:   3.772


× No keyword cloud information.
  20 in total

1.  Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis.

Authors:  Thomas J Richards; Naftali Kaminski; Fred Baribaud; Susan Flavin; Carrie Brodmerkel; Daniel Horowitz; Katherine Li; Jiin Choi; Louis J Vuga; Kathleen O Lindell; Melinda Klesen; Yingze Zhang; Kevin F Gibson
Journal:  Am J Respir Crit Care Med       Date:  2012-01-01       Impact factor: 21.405

Review 2.  Lung organoids: current uses and future promise.

Authors:  Christina E Barkauskas; Mei-I Chung; Bryan Fioret; Xia Gao; Hiroaki Katsura; Brigid L M Hogan
Journal:  Development       Date:  2017-03-15       Impact factor: 6.868

3.  3D pulmospheres serve as a personalized and predictive multicellular model for assessment of antifibrotic drugs.

Authors:  Ranu Surolia; Fu Jun Li; Zheng Wang; Huashi Li; Gang Liu; Yong Zhou; Tracy Luckhardt; Sejong Bae; Rui-Ming Liu; Sunad Rangarajan; Joao de Andrade; Victor J Thannickal; Veena B Antony
Journal:  JCI Insight       Date:  2017-01-26

4.  Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance.

Authors:  Louise Hecker; Naomi J Logsdon; Deepali Kurundkar; Ashish Kurundkar; Karen Bernard; Thomas Hock; Eric Meldrum; Yan Y Sanders; Victor J Thannickal
Journal:  Sci Transl Med       Date:  2014-04-09       Impact factor: 17.956

5.  Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF.

Authors:  Paul F Mercer; Hannah V Woodcock; Jessica D Eley; Manuela Platé; Michal G Sulikowski; Pascal F Durrenberger; Linda Franklin; Carmel B Nanthakumar; Yim Man; Federica Genovese; Robin J McAnulty; Shuying Yang; Toby M Maher; Andrew G Nicholson; Andy D Blanchard; Richard P Marshall; Pauline T Lukey; Rachel C Chambers
Journal:  Thorax       Date:  2016-04-21       Impact factor: 9.139

Review 6.  Precision Medicine: The New Frontier in Idiopathic Pulmonary Fibrosis.

Authors:  Robert Brownell; Naftali Kaminski; Prescott G Woodruff; Williamson Z Bradford; Luca Richeldi; Fernando J Martinez; Harold R Collard
Journal:  Am J Respir Crit Care Med       Date:  2016-06-01       Impact factor: 21.405

7.  Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis.

Authors:  Daryle J DePianto; Sanjay Chandriani; Alexander R Abbas; Guiquan Jia; Elsa N N'Diaye; Patrick Caplazi; Steven E Kauder; Sabyasachi Biswas; Satyajit K Karnik; Connie Ha; Zora Modrusan; Michael A Matthay; Jasleen Kukreja; Harold R Collard; Jackson G Egen; Paul J Wolters; Joseph R Arron
Journal:  Thorax       Date:  2014-09-12       Impact factor: 9.139

Review 8.  Precision medicine in idiopathic pulmonary fibrosis.

Authors:  T M Maher
Journal:  QJM       Date:  2016-08-10

9.  Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study.

Authors:  Jose D Herazo-Maya; Jiehuan Sun; Philip L Molyneaux; Qin Li; Julian A Villalba; Argyrios Tzouvelekis; Heather Lynn; Brenda M Juan-Guardela; Cristobal Risquez; Juan C Osorio; Xiting Yan; George Michel; Nachelle Aurelien; Kathleen O Lindell; Melinda J Klesen; Miriam F Moffatt; William O Cookson; Yingze Zhang; Joe G N Garcia; Imre Noth; Antje Prasse; Ziv Bar-Joseph; Kevin F Gibson; Hongyu Zhao; Erica L Herzog; Ivan O Rosas; Toby M Maher; Naftali Kaminski
Journal:  Lancet Respir Med       Date:  2017-09-21       Impact factor: 30.700

10.  Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis.

Authors:  Tasha E Fingerlin; Elissa Murphy; Weiming Zhang; Anna L Peljto; Kevin K Brown; Mark P Steele; James E Loyd; Gregory P Cosgrove; David Lynch; Steve Groshong; Harold R Collard; Paul J Wolters; Williamson Z Bradford; Karl Kossen; Scott D Seiwert; Roland M du Bois; Christine Kim Garcia; Megan S Devine; Gunnar Gudmundsson; Helgi J Isaksson; Naftali Kaminski; Yingze Zhang; Kevin F Gibson; Lisa H Lancaster; Joy D Cogan; Wendi R Mason; Toby M Maher; Philip L Molyneaux; Athol U Wells; Miriam F Moffatt; Moises Selman; Annie Pardo; Dong Soon Kim; James D Crapo; Barry J Make; Elizabeth A Regan; Dinesha S Walek; Jerry J Daniel; Yoichiro Kamatani; Diana Zelenika; Keith Smith; David McKean; Brent S Pedersen; Janet Talbert; Raven N Kidd; Cheryl R Markin; Kenneth B Beckman; Mark Lathrop; Marvin I Schwarz; David A Schwartz
Journal:  Nat Genet       Date:  2013-04-14       Impact factor: 38.330
View more
  1 in total

Review 1.  Mechanisms for the Resolution of Organ Fibrosis.

Authors:  Jeffrey C Horowitz; Victor J Thannickal
Journal:  Physiology (Bethesda)       Date:  2019-01-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.